Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Peptic Ulcer

  Free Subscription


27.05.2019

1 Aliment Pharmacol Ther
1 Gastroenterology
2 Gastrointest Endosc
2 Gut
8 Helicobacter
2 J Gastroenterol Hepatol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. RONKAINEN J, Aro P, Walker MM, Agreus L, et al
    Duodenal eosinophilia is associated with functional dyspepsia and new onset gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2019 May 20. doi: 10.1111/apt.15308.
    PubMed     Text format     Abstract available


    Gastroenterology

  2. SUGIYAMA T
    Understanding the current evidence on proton pump inhibitor use and bone health.
    Gastroenterology. 2019 May 15. pii: S0016-5085(19)40886.
    PubMed     Text format    


    Gastrointest Endosc

  3. AOKI T, Yamada A, Aoyama K, Saito H, et al
    Automatic detection of erosions and ulcerations in wireless capsule endoscopy images based on a deep convolutional neural network.
    Gastrointest Endosc. 2019;89:357-363.
    PubMed     Text format     Abstract available

  4. DURAN RG, Garcia-Rodriguez A, Cordova H, Cuatrecasas M, et al
    Association between a regular arrangement of collecting venules and absence of Helicobacter pylori infection in a European population.
    Gastrointest Endosc. 2019 May 17. pii: S0016-5107(19)31719.
    PubMed     Text format     Abstract available


    Gut

  5. GUO CG, Cheung KS, Zhang F, Chan EW, et al
    Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for Helicobacter pylori: a territory-wide cohort study.
    Gut. 2019 May 17. pii: gutjnl-2019-318352. doi: 10.1136/gutjnl-2019-318352.
    PubMed     Text format     Abstract available

  6. DOORAKKERS E, Lagergren J, Engstrand L, Brusselaers N, et al
    Reply to: Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a western population.
    Gut. 2019 May 21. pii: gutjnl-2019-319000. doi: 10.1136/gutjnl-2019-319000.
    PubMed     Text format    


    Helicobacter

  7. OGAWA T, Wada Y, Takemura K, Board PG, et al
    CHAC1 overexpression in human gastric parietal cells with Helicobacter pylori infection in the secretory canaliculi.
    Helicobacter. 2019 May 20:e12598. doi: 10.1111/hel.12598.
    PubMed     Text format     Abstract available

  8. LEE JH, Ahn JY, Choi KD, Jung HY, et al
    Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study.
    Helicobacter. 2019 May 20:e12592. doi: 10.1111/hel.12592.
    PubMed     Text format     Abstract available

  9. YU L, Luo L, Long X, Liang X, et al
    High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial.
    Helicobacter. 2019 May 20:e12596. doi: 10.1111/hel.12596.
    PubMed     Text format     Abstract available

  10. KATO M, Ota H, Okuda M, Kikuchi S, et al
    Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.
    Helicobacter. 2019 May 20:e12597. doi: 10.1111/hel.12597.
    PubMed     Text format     Abstract available

  11. ORTIZ V, Estevez-Ordonez D, Montalvan-Sanchez E, Urrutia-Argueta S, et al
    Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low-resource Central America setting.
    Helicobacter. 2019 May 20:e12595. doi: 10.1111/hel.12595.
    PubMed     Text format     Abstract available

  12. MCNICHOLL AG, Amador J, Ricote M, Canones-Garzon PJ, et al
    Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions.
    Helicobacter. 2019 May 20:e12593. doi: 10.1111/hel.12593.
    PubMed     Text format     Abstract available

  13. SONG C, Qian X, Zhu Y, Shu X, et al
    Effectiveness and safety of furazolidone-containing quadruple regimens in patients with Helicobacter pylori infection in real-world practice.
    Helicobacter. 2019 May 20:e12591. doi: 10.1111/hel.12591.
    PubMed     Text format     Abstract available

  14. GU L, Li S, He Y, Chen Y, et al
    Bismuth, rabeprazole, amoxicillin, and doxycycline as first-line Helicobacter pylori therapy in clinical practice: A pilot study.
    Helicobacter. 2019 May 22:e12594. doi: 10.1111/hel.12594.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  15. HSU PI, Pan CY, Kao JY, Tsay FW, et al
    Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.
    J Gastroenterol Hepatol. 2019 May 22. doi: 10.1111/jgh.14736.
    PubMed     Text format     Abstract available

  16. ADACHI K, Notsu T, Mishiro T, Kinoshita Y, et al
    Long-term effect of Helicobacter pylori eradication on prevalence of reflux esophagitis.
    J Gastroenterol Hepatol. 2019 May 21. doi: 10.1111/jgh.14730.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: